Northern Trust’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.61M | Buy |
414,956
+58,490
| +16% | +$739K | ﹤0.01% | 2492 |
|
|
2025
Q4 | $5.91M | Sell |
356,466
-1,112
| -0.3% | -$15.9K | ﹤0.01% | 2373 |
|
|
2025
Q3 | $4.21M | Sell |
357,578
-1,746
| -0.5% | -$18K | ﹤0.01% | 2604 |
|
|
2025
Q2 | $3.45M | Sell |
359,324
-27,299
| -7% | -$151K | ﹤0.01% | 2688 |
|
|
2025
Q1 | $2.42M | Sell |
386,623
-11,341
| -3% | -$68.9K | ﹤0.01% | 2817 |
|
|
2024
Q4 | $3.23M | Buy |
397,964
+77,189
| +24% | +$956K | ﹤0.01% | 2766 |
|
|
2024
Q3 | $5.8M | Buy |
320,775
+44,115
| +16% | +$617K | ﹤0.01% | 2394 |
|
|
2024
Q2 | $2.85M | Sell |
276,660
-6,540
| -2% | -$67.4K | ﹤0.01% | 2712 |
|
|
2024
Q1 | $3.01M | Sell |
283,200
-6,619
| -2% | -$56.2K | ﹤0.01% | 2760 |
|
|
2023
Q4 | $2.65M | Buy |
289,819
+21,043
| +8% | +$181K | ﹤0.01% | 2843 |
|
|
2023
Q3 | $2.79M | Buy |
268,776
+51,590
| +24% | +$708K | ﹤0.01% | 2759 |
|
|
2023
Q2 | $3.11M | Buy |
217,186
+4,285
| +2% | +$49.4K | ﹤0.01% | 2761 |
|
|
2023
Q1 | $1.52M | Buy |
212,901
+1,852
| +0.9% | +$16.3K | ﹤0.01% | 3060 |
|
|
2022
Q4 | $2.37M | Buy |
211,049
+19,340
| +10% | +$199K | ﹤0.01% | 2911 |
|
|
2022
Q3 | $2.12M | Buy |
191,709
+1,821
| +1% | +$17.4K | ﹤0.01% | 2985 |
|
|
2022
Q2 | $1.6M | Buy |
189,888
+11,078
| +6% | +$114K | ﹤0.01% | 3174 |
|
|
2022
Q1 | $2.43M | Sell |
178,810
-9,095
| -5% | -$147K | ﹤0.01% | 3004 |
|
|
2021
Q4 | $3.7M | Buy |
187,905
+1,829
| +1% | +$43K | ﹤0.01% | 2888 |
|
|
2021
Q3 | $5.97M | Sell |
186,076
-8,800
| -5% | -$292K | ﹤0.01% | 2619 |
|
|
2021
Q2 | $6.6M | Buy |
194,876
+63,020
| +48% | +$2.26M | ﹤0.01% | 2659 |
|
|
2021
Q1 | $4.95M | Buy |
131,856
+535
| +0.4% | +$22.4K | ﹤0.01% | 2749 |
|
|
2020
Q4 | $4.36M | Sell |
131,321
-1,127
| -0.9% | -$45.7K | ﹤0.01% | 2759 |
|
|
2020
Q3 | $4.86M | Sell |
132,448
-11,005
| -8% | -$381K | ﹤0.01% | 2549 |
|
|
2020
Q2 | $4.72M | Buy |
143,453
+12,195
| +9% | +$469K | ﹤0.01% | 2562 |
|
|
2020
Q1 | $3.39M | Buy |
131,258
+16,832
| +15% | +$563K | ﹤0.01% | 2530 |
|
|
2019
Q4 | $3.56M | Buy |
+114,426
| New | +$2.88M | ﹤0.01% | 2789 |
|
Other funds holding PHAT
FLSM
MVM
CG
VCM
NMC
6CM
